Spacer
Home Intranet Email

FyMed Inc

Precision Medicine Banner


Specialty Diagnostics and Clinical Trial Support for Early Diagnosis and Treatment Strategies
Diagnostics Link
New Developments
Oncology Trial Image 2011
Launched CRO services for global clinical trials: Supporting biotech innovation
Anti-inflammatory Image 2012
FyMed identifies new anti-inflammatory formulation: Studies show huge potential for new NSAID strategies
MDT Acquisition Image 2012
FyMed acquires MDT - Molecular Diagnostics & Therapeutics: Discovery studies now in full swing
FY10 Technology Image 2013
Scientists at FyMed complete devpt of FY10 technology: Results reveal unique NSAID target profiles
Clinical Trial Tech Image 2015
Examination of FyMed's clinical trial technologies: Precision medicine now peer reviewed as revolutionary
NSAID Candidate Image 2018
Lead FyMed NSAID candidate FY103B: Studies demonstrate superiority over celecoxib and naproxen
Antineoplastic Drug Image 2019
FyMed develops novel antineoplastic drug: Comparisons in tumor xenografts indicate substantial benefit
Oncology Trial Support Image 2020
Supported clinical trial for a biotech partner: Advancing oncology research
Improving Clinical Outcomes with Novel Molecular Therapeutics in Translational Medicine
Therapeutics Link
About FyMed
FyMed Team Image Physicians and Scientists collaborate on several projects with FyMed. Our quest is to continue identification, characterization, and development of novel biomarkers and promising therapeutic targets. FyMed now supports clients with clinical trial management and research services to accelerate drug development.

Leading innovations in precision medicine, has enabled FyMed to effectively balance technological innovation with scientific discovery, creating tools that can productively capitalize on key market deficiencies.

FyMed has established relationships with large companies, allowing us to collaborate and conduct clinical studies on a global scale. FyMed uses novel applications in bioinformatics and R&D tools that are closely integrated with the development of clinical studies enabling prolific product characterization and continued growth.

Our molecular-based precision medicine approach allows for targeting modalities with innovative techniques that are focused and comprehensive.

Now, you can be a part of this vital venture! Contact us for clinical research partnerships or to utilize our proprietary methodologies in evidence-based medicine for drug discoveries.

FyMed Press Releases

Click here
for Company Press Releases


Twitter  LinkedIn  Facebook
Advancing Hope by Breakthrough Medical Research and Developing New Pathways to Cures
Discovery Link
CRO Services

Clinical Trial Management

FyMed delivers end-to-end support for Phase I-IV trials, ensuring timely execution and regulatory compliance.


Preclinical Research

Our advanced preclinical studies accelerate drug development with robust data for IND submissions.


Regulatory Consulting

Navigate FDA and EMA requirements with our expert guidance for seamless approvals.


Data Analytics

Leverage our bioinformatics tools for precise clinical data analysis and actionable insights.


Global Study Coordination

Partner with FyMed for multi-site trials, managed with precision across global regions.

Press Releases | Diagnostics | Therapeutics | Discovery | Intranet | Contacts

FyMed, Inc.
Leading Innovations in Precision Medicine ™
Pharmaceuticals: 103 Carnegie Center Dr, #300, Princeton, NJ 08540
Corporate: 3422 Old Capitol Rd, #1610, Wilmington, DE 19808

USA Tel: +1 302-722-5010 | Fax: +1 302-722-5011
UK Tel: +44 1844 220 090 | ask@fymedinc.com

Copyright © FyMed, Inc. | All Rights Reserved